Medidata the leading global provider of cloud-based solutions for clinical research in life sciences, announced Michael L. Capone is joining the company as chief operating officer COO.

Global equity markets fell on Monday as civil unrest in Hong Kong weighed on investor sentiment, while U.S. Treasury debt prices rose over uncertainty sparked by the protests.

Based upon pre-existing and clear data on safety & efficacy, it is very likely that the Provectus (PVCT) Phase III pivotal melanoma trial will demonstrate the safety and efficacy of PV-10 to the market and to prospective acquirers very much earlier than many have presumed.